Abstract
The use of baclofen in neonates has been minimally reported. We report on two term neonates who were treated successfully for hypertonia with baclofen.
Similar content being viewed by others
References
Young RR, Delwaide PJ . Drug therapy: spasticity (second of two parts). N Engl J Med 1981;304:96–99.
Sweetman S, editor. Martindale: The Complete Drug Reference. London: Pharmaceutical Press Electronic version, MICROMEDEX, Greenwood Village, CO (Edition expires 3/2004).
Bohannon RW, Smith MB . Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987;67:206–207.
Fosang AL, Galea MP, McCoy AT . Measurement of muscle and joint performance in the lower limb of children with cerebral palsy. Dev Med Child Neurol 2003;45:664–670.
Sanger TD, Delgado MR, Gaebler-Spira D . Classification and definition of disorders causing hypertonia in childhood. Pediatrics 2003;111:89–97.
Terrance CF, Fromm GH, Roussau MS . Baclofen: its effects on seizure frequency. Arch Neurol 1983;40:28–29.
Hansel DE, Hansel CR, Shindle MK, et al. Oral baclofen in cerebral palsy: possible seizure potentiation? Pediatr Neurol 2003;29:203–206.
Ratnayaka BDM, Dhaliwal H, Watkin S . Neonatal convulsions after withdrawal of baclofen. BMJ 2001;323:85.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moran, L., Cincotta, T., Krishnamoorthy, K. et al. The Use of Baclofen in Full-Term Neonates with Hypertonia. J Perinatol 25, 66–68 (2005). https://doi.org/10.1038/sj.jp.7211194
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7211194
- Springer Nature America, Inc.
This article is cited by
-
Gastroesophageal Reflux Disease in Neonates and Infants
Pediatric Drugs (2013)